Viewing Study NCT01239459


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2025-12-26 @ 4:34 AM
Study NCT ID: NCT01239459
Status: COMPLETED
Last Update Posted: 2012-03-01
First Post: 2010-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module